View in EDS HTML Full Text PDF Full Text

Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.

Saved in:
Bibliographic Details
Title: Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.
Authors: Kimura S; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan. mochinag@cc.saga-u.ac.jp., Katsuya H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Nakashima C; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sueoka-Aragane N; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Hayashida K; Department of Medical Information, Saga University Hospital, Saga City, Saga, Japan., Sasaki K; Cancer Center, Saga University Hospital, Saga City, Saga, Japan., Sogawa R; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan., Furuno T; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan., Yamauchi M; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sugiyama Y; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Noshiro H; Department of Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Esaki M; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Noguchi M; Department of Urology, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Takahashi H; Liver Center, Faculty of Medicine, Saga University Hospital, Saga University, Saga City, Saga, Japan., Anzai K; Division of Metabolism and Endocrinology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Yokoyama M; Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Sugita K; Division of Dermatology, Department Of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Yamashita Y; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan., Shimanoe C; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan.
Source: BMC immunology [BMC Immunol] 2025 Apr 16; Vol. 26 (1), pp. 33. Date of Electronic Publication: 2025 Apr 16.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172 (Electronic) Linking ISSN: 14712172 NLM ISO Abbreviation: BMC Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40240963
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kimura+S%22">Kimura S</searchLink>; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan. mochinag@cc.saga-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Katsuya+H%22">Katsuya H</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Nakashima+C%22">Nakashima C</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Sueoka-Aragane+N%22">Sueoka-Aragane N</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Hayashida+K%22">Hayashida K</searchLink>; Department of Medical Information, Saga University Hospital, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Cancer Center, Saga University Hospital, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Sogawa+R%22">Sogawa R</searchLink>; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Furuno+T%22">Furuno T</searchLink>; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan.<br /><searchLink fieldCode="AU" term="%22Yamauchi+M%22">Yamauchi M</searchLink>; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+Y%22">Sugiyama Y</searchLink>; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Noshiro+H%22">Noshiro H</searchLink>; Department of Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Esaki+M%22">Esaki M</searchLink>; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Noguchi+M%22">Noguchi M</searchLink>; Department of Urology, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Liver Center, Faculty of Medicine, Saga University Hospital, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Anzai+K%22">Anzai K</searchLink>; Division of Metabolism and Endocrinology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoyama+M%22">Yokoyama M</searchLink>; Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Sugita+K%22">Sugita K</searchLink>; Division of Dermatology, Department Of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+Y%22">Yamashita Y</searchLink>; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Kawaguchi+A%22">Kawaguchi A</searchLink>; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+S%22">Kimura S</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga City, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Shimanoe+C%22">Shimanoe C</searchLink>; Department of Pharmacy, Saga University Hospital, 5-1-1 Nabeshima, Saga City, Saga, 849-8501, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100966980%22">BMC immunology</searchLink> [BMC Immunol] 2025 Apr 16; Vol. 26 (1), pp. 33. <i>Date of Electronic Publication: </i>2025 Apr 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100966980 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712172%22">14712172 </searchLink><i>NLM ISO Abbreviation: </i>BMC Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40240963
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12865-025-00711-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 33
    Titles:
      – TitleFull: Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kimura S
      – PersonEntity:
          Name:
            NameFull: Katsuya H
      – PersonEntity:
          Name:
            NameFull: Nakashima C
      – PersonEntity:
          Name:
            NameFull: Sueoka-Aragane N
      – PersonEntity:
          Name:
            NameFull: Hayashida K
      – PersonEntity:
          Name:
            NameFull: Sasaki K
      – PersonEntity:
          Name:
            NameFull: Sogawa R
      – PersonEntity:
          Name:
            NameFull: Furuno T
      – PersonEntity:
          Name:
            NameFull: Yamauchi M
      – PersonEntity:
          Name:
            NameFull: Sugiyama Y
      – PersonEntity:
          Name:
            NameFull: Noshiro H
      – PersonEntity:
          Name:
            NameFull: Esaki M
      – PersonEntity:
          Name:
            NameFull: Noguchi M
      – PersonEntity:
          Name:
            NameFull: Takahashi H
      – PersonEntity:
          Name:
            NameFull: Anzai K
      – PersonEntity:
          Name:
            NameFull: Yokoyama M
      – PersonEntity:
          Name:
            NameFull: Sugita K
      – PersonEntity:
          Name:
            NameFull: Yamashita Y
      – PersonEntity:
          Name:
            NameFull: Kawaguchi A
      – PersonEntity:
          Name:
            NameFull: Kimura S
      – PersonEntity:
          Name:
            NameFull: Shimanoe C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 04
              Text: 2025 Apr 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2172
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC immunology
              Type: main
ResultId 1